Humana Inc. (NYSE:HUM) to Post FY2024 Earnings of $16.04 Per Share, Cantor Fitzgerald Forecasts

Humana Inc. (NYSE:HUM) – Cantor Fitzgerald reduced their FY2024 EPS estimates for Humana in a research note issued on Thursday, April 25th. Cantor Fitzgerald analyst S. James now forecasts that the insurance provider will post earnings per share of $16.04 for the year, down from their prior estimate of $16.07. Cantor Fitzgerald currently has a “Neutral” rating and a $360.00 price target on the stock. The consensus estimate for Humana’s current full-year earnings is $16.06 per share.

Several other research analysts have also commented on the stock. Oppenheimer dropped their price objective on shares of Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a research note on Thursday. Barclays dropped their price objective on shares of Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a research note on Tuesday, April 2nd. Wells Fargo & Company dropped their price objective on shares of Humana from $413.00 to $350.00 and set an “overweight” rating for the company in a research note on Monday, April 8th. Mizuho dropped their price objective on shares of Humana from $550.00 to $400.00 and set a “buy” rating for the company in a research note on Friday, January 26th. Finally, Bank of America reaffirmed a “neutral” rating and set a $342.00 price objective (down from $470.00) on shares of Humana in a research note on Tuesday, April 2nd. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, Humana currently has a consensus rating of “Hold” and an average target price of $433.74.

Humana Trading Down 0.1 %

HUM stock opened at $311.00 on Friday. The firm has a fifty day moving average price of $328.56 and a 200 day moving average price of $395.71. Humana has a fifty-two week low of $299.23 and a fifty-two week high of $541.21. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.59 and a current ratio of 1.67. The firm has a market cap of $37.52 billion, a PE ratio of 19.39, a price-to-earnings-growth ratio of 1.85 and a beta of 0.45.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm had revenue of $29.61 billion during the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the firm posted $9.38 earnings per share. Humana’s revenue for the quarter was up 10.7% compared to the same quarter last year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of HUM. Dorsey & Whitney Trust CO LLC increased its position in shares of Humana by 2.6% during the third quarter. Dorsey & Whitney Trust CO LLC now owns 817 shares of the insurance provider’s stock worth $397,000 after purchasing an additional 21 shares in the last quarter. UMB Bank n.a. grew its stake in Humana by 2.8% during the 3rd quarter. UMB Bank n.a. now owns 805 shares of the insurance provider’s stock worth $392,000 after buying an additional 22 shares during the last quarter. First Financial Corp IN grew its stake in Humana by 7.2% during the 4th quarter. First Financial Corp IN now owns 343 shares of the insurance provider’s stock worth $157,000 after buying an additional 23 shares during the last quarter. PDS Planning Inc grew its stake in Humana by 4.1% during the 3rd quarter. PDS Planning Inc now owns 609 shares of the insurance provider’s stock worth $296,000 after buying an additional 24 shares during the last quarter. Finally, First Trust Direct Indexing L.P. grew its stake in Humana by 0.8% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 2,926 shares of the insurance provider’s stock worth $1,424,000 after buying an additional 24 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Jorge S. Mesquita bought 545 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was bought at an average cost of $367.09 per share, with a total value of $200,064.05. Following the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.32% of the company’s stock.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.14%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.